(Q43875103)

27 November 2017

title

PSA screening: determinants of primary-care physician practice patterns (English)

1 reference

27 November 2017

G E Tasian

1

1 reference

27 November 2017

M R Cooperberg

2

1 reference

27 November 2017

M B Potter

3

1 reference

27 November 2017

J E Cowan

4

1 reference

27 November 2017

K L Greene

5

1 reference

27 November 2017

P R Carroll

6

1 reference

27 November 2017

J M Chan

7

1 reference

27 November 2017

publication date

29 November 2011

1 reference

Prostate Cancer and Prostatic Diseases

27 November 2017

published in

1 reference

27 November 2017

volume

15

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

189-194

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2011.59

27 November 2017

exact match

0 references

cites work

Outcomes of active surveillance for men with intermediate-risk prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Outcomes and follow-up strategies for patients on active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Prostate specific antigen best practice statement: 2009 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

American Cancer Society guideline for the early detection of prostate cancer: update 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Imaging use and cryptorchidism: determinants of practice patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Discussions about prostate cancer screening between U.S. primary care physicians and their patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Practice trends in the management of prostate disease by family practice physicians and general internists: an internet-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Influence of publication of US and European prostate cancer screening trials on PSA testing practices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Knowledge and use of finasteride for the prevention of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Understanding the relation between research and clinical policy: a study of clinicians' views

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Radical prostatectomy versus watchful waiting in early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Response rates and response bias for 50 surveys of pediatricians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Response rates to mail surveys published in medical journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Long-term Survival Among Men With Conservatively Treated Localized Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinical

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.59

31 March 2020

Identifiers

DOI

10.1038/PCAN.2011.59

1 reference

Dimensions Publication ID

27 November 2017

1000800042

0 references

1 reference